Global X Genomics & Biotechnology ETF GNOM
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.50%
- Net assets
- $55.8M
- Holdings
- 51
- 12-month distribution yield
- 0.97%
- Asset class
- Equity
Global X Genomics & Biotechnology ETF (GNOM) is an exchange-traded fund listed on the Nasdaq in the United States, issued by Global X. Its category is Equity · US (equity). Its last price was US$67.25 on 20 Oct 2026. Its expense ratio is 0.5% a year, from its prospectus dated 1 Apr 2026. It reported net assets of US$55.79 million as of 31 May 2026. Its latest holdings report lists 51 holdings as of 31 May 2026. Over the last 12 months it paid distributions of US$0.65 a unit, a 12-month distribution yield of 0.97%, paid twice a year.
Fees
- Total annual operating expenses (gross)
- 0.50%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.50%
- Prospectus date
- 1 Apr 2026
- Filed with the SEC
- 27 Mar 2026
Size and reporting
- Net assets
- $55,791,483
- Total assets
- $55,812,463
- Holdings as of
- 31 May 2026
- Report made public
- 29 Jul 2026 (59 days after the month end)
Top holdings
Largest 25 of 51 positions, as of 31 May 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | GUARDANT HEALTH, INC. GUARDANT HEALTH INC COMMON STOCK | US40131M1099 | 5.59% | $3.1M | Equity (common) | United States | USD |
| 2 | ILLUMINA, INC. ILLUMINA INC COMMON STOCK | US4523271090 | 4.82% | $2.7M | Equity (common) | United States | USD |
| 3 | NATERA, INC. NATERA INC COMMON STOCK | US6323071042 | 4.15% | $2.3M | Equity (common) | United States | USD |
| 4 | BIOMARIN PHARMACEUTICAL INC. BIOMARIN PHARMACEUTICAL INC COMMON STOCK | US09061G1013 | 4.09% | $2.3M | Equity (common) | United States | USD |
| 5 | ARROWHEAD PHARMACEUTICALS, INC. ARROWHEAD PHARMACEUTICALS IN COMMON STOCK | US04280A1007 | 4.07% | $2.3M | Equity (common) | United States | USD |
| 6 | Legend Biotech Corp LEGEND BIOTECH CORP-ADR DEPOSITARY RECEIPT | US52490G1022 | 4.05% | $2.3M | Equity (common) | United States | USD |
| 7 | Praxis Precision Medicines Inc PRAXIS PRECISION MEDICINES I COMMON STOCK | US74006W2070 | 4.01% | $2.2M | Equity (common) | United States | USD |
| 8 | Twist Bioscience Corp TWIST BIOSCIENCE CORP COMMON STOCK | US90184D1000 | 3.97% | $2.2M | Equity (common) | United States | USD |
| 9 | VERTEX PHARMACEUTICALS INCORPORATED VERTEX PHARMACEUTICALS INC COMMON STOCK | US92532F1003 | 3.95% | $2.2M | Equity (common) | United States | USD |
| 10 | CRISPR Therapeutics AG CRISPR THERAPEUTICS AG COMMON STOCK | CH0334081137 | 3.85% | $2.1M | Equity (common) | United States | USD |
| 11 | Veracyte Inc VERACYTE INC COMMON STOCK | US92337F1075 | 3.64% | $2.0M | Equity (common) | United States | USD |
| 12 | Qiagen N.V. QIAGEN N.V. COMMON STOCK | NL0015002SN0 | 3.54% | $2.0M | Equity (common) | United States | USD |
| 13 | BioNTech SE BIONTECH SE-ADR DEPOSITARY RECEIPT | US09075V1026 | 3.41% | $1.9M | Equity (common) | United States | USD |
| 14 | BIO-TECHNE CORPORATION BIO-TECHNE CORP COMMON STOCK | US09073M1045 | 3.41% | $1.9M | Equity (common) | United States | USD |
| 15 | MODERNA, INC. MODERNA INC COMMON STOCK | US60770K1079 | 3.28% | $1.8M | Equity (common) | United States | USD |
| 16 | 10X Genomics Inc 10X GENOMICS INC-CLASS A COMMON STOCK | US88025U1097 | 3.23% | $1.8M | Equity (common) | United States | USD |
| 17 | Beam Therapeutics Inc BEAM THERAPEUTICS INC COMMON STOCK | US07373V1052 | 3.09% | $1.7M | Equity (common) | United States | USD |
| 18 | BNYREPOS | No identifier reported | 3.05% | $1.7M | Repurchase agreements | United States | USD |
| 19 | ELI LILLY AND COMPANY ELI LILLY & CO COMMON STOCK | US5324571083 | 2.32% | $1.3M | Equity (common) | United States | USD |
| 20 | Ultragenyx Pharmaceutical Inc ULTRAGENYX PHARMACEUTICAL IN COMMON STOCK | US90400D1081 | 2.25% | $1.3M | Equity (common) | United States | USD |
| 21 | CARIS LIFE SCIENCES, INC. CARIS LIFE SCIENCES INC COMMON STOCK | US1421521071 | 2.03% | $1.1M | Equity (common) | United States | USD |
| 22 | Genscript Biotech Corp GENSCRIPT BIOTECH CORP COMMON STOCK | KYG3825B1059 | 2.00% | $1.1M | Equity (common) | Hong Kong | HKD |
| 23 | BillionToOne Inc BILLIONTOONE INC CL A COMMON STOCK | US0901681058 | 1.97% | $1.1M | Equity (common) | United States | USD |
| 24 | GILEAD SCIENCES, INC. GILEAD SCIENCES INC COMMON STOCK | US3755581036 | 1.95% | $1.1M | Equity (common) | United States | USD |
| 25 | ASTRAZENECA PLC ASTRAZENECA PLC COMMON STOCK | GB0009895292 | 1.83% | $1.0M | Equity (common) | United Kingdom | GBP |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.90% | |
| Repurchase agreements | 3.05% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 99.12% | |
| Hong Kong | 2.00% | |
| United Kingdom | 1.83% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 99.12% | |
| Hong Kong dollar (HKD) | 2.00% | |
| British pound (GBP) | 1.83% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 59.53% | |
| Industrials | 1.98% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.6490
- 12-month yield
- 0.97%
- Frequency
- Twice a year
- Latest ex-date
- 29 Jun 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.6490) ÷ latest price ($67.25) × 100 = 0.97%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (4 payments)
| Ex-date | Amount per unit |
|---|---|
| 29 Jun 2026 | $0.0580 |
| 30 Dec 2025 | $0.5910 |
| 27 Jun 2025 | $0.0320 |
| 30 Dec 2021 | $0.0280 |
Filings and sources
- Form N-PORT report for May 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000062676) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- GNOM and VTI Vanguard Morningstar Total Stock Market ETF
- GNOM and VOO Vanguard S&P 500 ETF
- GNOM and IVV iShares Core S&P 500 ETF
- GNOM and QQQ Invesco QQQ Trust, Series 1